14-day Premium Trial Subscription Try For FreeGet Free
$29.21
-0.160 (-0.545%)
At Close: Dec 08, 2023
Chart & Forecast Earnings Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Mon, 11 Dec 2023

Trading levels for IMGN

Support & Resistance - Acc. volume What is stop-loss?

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 29.45 0.82 %
R2 29.38 0.580 %
R1 29.34 0.430 %
Current price: 29.21
Support S1 29.19 -0.0536 %
S2 29.15 -0.203 %
S3 29.08 -0.445 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 29.35 0.479 %
R2 29.32 0.377 %
R1 29.22 0.0342 %
Current price 29.21
Support S1 0 .
S2 0 .
S3 0 .

IMGN Predictions History

4 months ago
 PredictionBot.Kathy predicted that IMGN for Jul. 21st is going $19.41 (2.20%)

4 months ago
 PredictionBot.Warren predicted that IMGN for Jul. 21st is going $19.29 (1.57%)

4 months ago
 ohyeasook.384155 predicted that IMGN for Jul. 21st is going

Rank:

4 months ago
 PredictionBot.Kathy predicted that IMGN for Jul. 17th is going $19.20 (-1.40%)

4 months ago
 PredictionBot.Warren predicted that IMGN for Jul. 17th is going $19.31 (-0.82%)

4 months ago
 duration4400 predicted that IMGN for Jul. 17th is going

Rank:

4 months ago
 PredictionBot.Kathy predicted that IMGN for Jul. 10th is going $18.69 (-0.53%)

4 months ago
 PredictionBot.Warren predicted that IMGN for Jul. 10th is going $18.57 (-1.19%)

4 months ago
 AlexVel predicted that IMGN for Jul. 10th is going $18.29 (-2.66%)

5 months ago
 AntonioBey predicted that IMGN for Jul. 7th is going

Rank:
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Golden Star

Ticker Date Change Price
SGEN Dec 04 2.74% $213.13
SJM Dec 01 7.10% $111.42
ESS Nov 30 5.93% $213.46
KMX Nov 30 5.13% $63.94
CVNA Nov 30 28.54% $31.32
ATKR Nov 30 4.10% $129.90
ENS Nov 30 4.49% $88.48
THS Nov 30 2.36% $40.71
AMRC Nov 29 12.03% $28.34
CP Nov 29 2.20% $71.32
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT